Study of Patients Being Treated With Anti-obesity Medication
Recruiting · NCT06790160 · Observational (researchers observe without assigning treatment) · Lead sponsor: Texas Tech University
View the official record on ClinicalTrials.gov →What this trial is about
The goal of this observational study is to learn about the real-world effects of selected obesity medications in adults undergoing medical weight management. The main outcomes of interest are changes in body composition, routine clinical markers, muscular performance, and nutritional intake over the course of treatment. Additionally, the influence of lifestyle factors on changes in these outcome variables will be examined. Participants beginning treatment with selected obesity medications will undergo periodic body composition and muscular performance testing, as well as complete online surveys about their nutritional intake and physical activity and exercise participation. Additionally, routinely collected clinical information will be evaluated.
Who can take part
Inclusion criteria
- Patient who is beginning treatment through Vineyard Virtual Health Clinic using semaglutide or tirzepatide. While the physician will individualize the treatment plans, the criteria for these medications will include, at a minimum: (A) a body mass index ≥30 kg/m2; OR (B) a BMI ≥27 kg/m2 plus at least one comorbidity.
- Patient who lives in drivable proximity to a city with an accepted DXA testing facility and is willing to report to the facility for periodic body composition testing.
Exclusion criteria
- Patients with type 2 diabetes.
- Patients who report not being willing or able to complete the assessments included in this research study.
- Patients who are currently pregnant or trying to become pregnant.
Where it is running
1 location listed across 1 US state.
- Texas Tech University - Lubbock, Texas, United States